logo BDSP

Base documentaire


  1. Is travel prophylaxis worth while ? Economic appraisal of prophylactic measures against malaria, hepatitis A, and typhoid in travellers.

    Article - En anglais

    Objective

    To estimate the costs and benefits of prophylaxis against travel acquired malaria, typhoid fever, and hepatitis A in United Kingdom residents during 1991.

    Design-Retrospective analysis of national epidemiological and economic data.

    Main outcome measures-Incidence of travel associated infections in susceptible United Kingdom residents per visit ; costs of prophylaxis provision from historical data ; benefits to the health sector, community, and individuals in terms of avoided morbidity and mortality based on hospital and community costs of disease.

    Results

    The high incidence of imported malaria (0.70%) and the low costs of providing chemoprophylaxis resulted in a cost-benefit ratio of 0.19 for chloroquine and proguanil and 0.57 for a regimen containing mefloquine.

    Mots-clés Pascal : Maladie d'importation, Paludisme, Protozoose, Infection, Hépatite virale A, Virose, Appareil digestif pathologie, Foie pathologie, Homme, Thyroïde, Prévention, Coût, Economie santé, Immunoprophylaxie

    Mots-clés Pascal anglais : Imported disease, Malaria, Protozoal disease, Infection, Viral hepatitis A, Viral disease, Digestive diseases, Hepatic disease, Human, Thyroid gland, Prevention, Costs, Health economy, Immunoprophylaxis

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 94-0704689

    Code Inist : 002B05A02. Création : 09/06/1995.